Moran Wealth Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $871K | Sell |
15,761
-134
| -0.8% | -$7.41K | 0.03% | 334 |
|
|
2025
Q1 | $769K | Sell |
15,895
-66
| -0.4% | -$3.19K | 0.03% | 328 |
|
|
2024
Q4 | $616K | Buy |
15,961
+931
| +6% | +$35.9K | 0.02% | 351 |
|
|
2024
Q3 | $676K | Buy |
15,030
+3,250
| +28% | +$146K | 0.02% | 344 |
|
|
2024
Q2 | $408K | Buy |
11,780
+1,044
| +10% | +$36.2K | 0.01% | 355 |
|
|
2024
Q1 | $311K | Buy |
+10,736
| New | +$311K | 0.01% | 376 |
|